4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Mizuho Medy Co.,Ltd. (4595) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Tosu, Japan with about 193 employees. Its market capitalization is roughly JPY 33 billion. In the fiscal year ended 2025-12-31, 4595 reported JPY 11.3B in revenue and JPY 3.4B in net income.
Mizuho Medy Co.,Ltd. engages in the research and development, manufacture, and sale of in vitro diagnostic products, and related scientific and technical information services in Japan.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | JPY 11.3B | JPY 11.4B | JPY 11.0B | JPY 17.6B | — |
| Gross Profit | JPY 7.8B | JPY 8.1B | JPY 8.1B | JPY 14.1B | — |
| Operating Income (EBIT) | JPY 4.7B | JPY 4.9B | JPY 5.2B | JPY 11.1B | — |
| Net Income | JPY 3.4B | JPY 3.8B | JPY 3.8B | JPY 7.8B | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | (JPY 2.1B) | (JPY 2.1B) | (JPY 2.4B) | (JPY 1.6B) | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | JPY 22.4B | JPY 20.7B | JPY 18.9B | JPY 19.1B | — |
| Total Liabilities | JPY 3.7B | JPY 3.4B | JPY 3.3B | JPY 4.8B | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4595 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms